Skip to main content
Journal cover image

Published In

Leukemia Research

DOI

ISSN

0145-2126

Publication Date

May 1, 2009

Volume

33

Issue

SUPPL. 1

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
de Castro, C., Adams, D., Rizzieri, D., Moore, J., Gockerman, J., Diehl, L., … Warzecho, J. (2009). P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes. Leukemia Research, 33(SUPPL. 1). https://doi.org/10.1016/S0145-2126(09)70215-2
Castro, C. de, D. Adams, D. Rizzieri, J. Moore, J. Gockerman, L. Diehl, M. Horwitz, E. Edmonds, and J. Warzecho. “P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes.” Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). https://doi.org/10.1016/S0145-2126(09)70215-2.
de Castro C, Adams D, Rizzieri D, Moore J, Gockerman J, Diehl L, et al. P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes. Leukemia Research. 2009 May 1;33(SUPPL. 1).
de Castro, C., et al. “P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes.” Leukemia Research, vol. 33, no. SUPPL. 1, May 2009. Scopus, doi:10.1016/S0145-2126(09)70215-2.
de Castro C, Adams D, Rizzieri D, Moore J, Gockerman J, Diehl L, Horwitz M, Edmonds E, Warzecho J. P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes. Leukemia Research. 2009 May 1;33(SUPPL. 1).
Journal cover image

Published In

Leukemia Research

DOI

ISSN

0145-2126

Publication Date

May 1, 2009

Volume

33

Issue

SUPPL. 1

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences